A detailed history of Siemens Fonds Invest Gmb H transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Siemens Fonds Invest Gmb H holds 12,567 shares of VRTX stock, worth $5.13 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
12,567
Previous 13,279 5.36%
Holding current value
$5.13 Million
Previous $6.22 Million 6.11%
% of portfolio
0.43%
Previous 0.47%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$460.0 - $505.78 $327,520 - $360,115
-712 Reduced 5.36%
12,567 $5.84 Million
Q2 2024

Aug 14, 2024

BUY
$392.81 - $485.53 $42,816 - $52,922
109 Added 0.83%
13,279 $6.22 Million
Q1 2024

May 15, 2024

SELL
$407.69 - $446.08 $179,791 - $196,721
-441 Reduced 3.24%
13,170 $5.51 Million
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $1.07 Million - $1.28 Million
3,111 Added 29.63%
13,611 $5.54 Million
Q3 2023

Nov 14, 2023

BUY
$338.18 - $362.46 $831,246 - $890,926
2,458 Added 30.56%
10,500 $3.65 Million
Q1 2023

May 15, 2023

BUY
$283.23 - $323.1 $27,190 - $31,017
96 Added 1.21%
8,042 $2.53 Million
Q4 2022

Feb 14, 2023

BUY
$285.76 - $321.48 $1,714 - $1,928
6 Added 0.08%
7,946 $2.29 Million
Q3 2022

Nov 14, 2022

SELL
$273.83 - $305.53 $67,088 - $74,854
-245 Reduced 2.99%
7,940 $2.3 Million
Q2 2022

Aug 15, 2022

SELL
$234.96 - $292.55 $4,934 - $6,143
-21 Reduced 0.26%
8,185 $2.31 Million
Q4 2021

Feb 14, 2022

BUY
$177.01 - $223.45 $67,440 - $85,134
381 Added 4.87%
8,206 $1.83 Million
Q3 2021

Nov 15, 2021

BUY
$181.39 - $202.99 $1.42 Million - $1.59 Million
7,825 New
7,825 $1.42 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Siemens Fonds Invest Gmb H Portfolio

Follow Siemens Fonds Invest Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Siemens Fonds Invest Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Siemens Fonds Invest Gmb H with notifications on news.